查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968595

基層醫療即時診斷市場分析及預測（至2035年）：按類型、產品類型、服務、技術、應用、最終用戶、設備、部署類型、安裝類型和解決方案照護現場

Primary Care PoC Diagnostics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Device, Deployment, Installation Type, Solutions
出版日期: | 出版商: Global Insight Services | 英文 422 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到2034年，基層醫療即時診斷（PoC）市場規模將從2024年的197億美元成長至267億美元，複合年成長率約為3.1%。基層醫療PoC診斷市場涵蓋分散式檢查解決方案，可在診療現場快速提供診斷結果。這些工具能夠幫助基層醫療提供者更快地做出決策，從而提升患者管理水平並支持其工作。推動該市場成長的因素包括技術進步、慢性病盛行率上升以及以患者為中心的醫療保健模式的轉變。為了滿足日益成長的對高效、經濟的醫療保健服務的需求，創新正致力於提高診斷技術的準確性、連接性和易用性。

基層醫療即時診斷市場正經歷強勁成長，這主要得益於人們對快速、精準診斷解決方案日益成長的需求。傳染病檢查細分市場是成長最快的子細分市場，其成長動力主要來自對快速感染疾病檢測和管理的日益成長的需求。在該細分市場中，呼吸道感染和性行為感染感染檢測尤為突出，反映出人們預防保健意識的提高和相關措施的進步。血液檢測是第二大細分市場，受益於技術進步和血液相關疾病的日益增加。數位技術和連接解決方案的整合正在提升即時診斷的能力，實現即時數據共用和更完善的患者管理。微流體和生物感測器的創新進一步拓展了診斷能力，提供了更全面、更微創的檢測選擇。隨著醫療保健系統日益注重以患者為中心的護理，對高效、分散式診斷解決方案的需求預計將推動市場成長，為相關人員創造豐厚的成長機會。

市場區隔
類型 橫向流動化驗、免疫檢測、分子診斷、血液學、臨床化學、微生物學、血液凝固檢驗、尿液檢查
產品 儀器、試劑盒、試劑、耗材、軟體
服務 安裝、維護、訓練、諮詢、資料管理
科技 生物感測器、微流體、實驗室晶片、核酸擴增、電化學檢測
應用領域 感染疾病、慢性病科、腫瘤科、心臟科、內分泌科、消化科、腎臟科、小兒科、婦科
最終用戶 醫院、診所、門診中心、居家醫療機構、檢查室、藥房和研究實驗室
裝置 手持式、桌上型、可攜式、穿戴式式
實施表格 本機部署、雲端部署、混合式部署
安裝類型 新安裝、維修和升級
解決方案 數據整合、遠端監控、病患管理、品管、工作流程最佳化

市場概況：

基層醫療照護現場診斷市場呈現出市場佔有率分佈多元化的特點，這主要受策略定價和創新產品發布的影響。各公司正致力於透過提供先進的診斷解決方案來拓展產品組合，從而增強自身的競爭優勢。基層醫療機構對快速、準確診斷的需求日益成長，推動了就地檢驗（POC​​T）的快速發展。技術進步以及需要及時干預和監測的慢性病病例的增加進一步促進了這一趨勢。競爭基準分析揭示了一個動態的市場環境，主要參與者正透過策略聯盟和收購來爭奪主導。監管的影響至關重要，嚴格的標準確保了診斷工具的可靠性和安全性。不同地區的監管環境差異塑造了市場格局，影響產品核可和打入市場策略。各公司正利用這些洞察來最佳化其市場定位，同時應對複雜的法規結構。診斷技術的創新進一步重塑了競爭格局，提供了成長機會和差異化優勢。

主要趨勢和促進因素：

受技術進步和慢性病發病率上升的推動，基層醫療即時診斷（PoC）市場正經歷強勁成長。關鍵趨勢包括人工智慧（AI）和機器學習的日益融合，這提高了診斷準確性和營運效率。對快速診斷和治療的需求推動了對快速檢測解決方案的需求，尤其是在農村和醫療資源匱乏的地區。此外，隨著個人化醫療的興起，診斷技術在製定針對每位患者需求的個人化治療方案中發揮關鍵作用。對預防性護理的日益重視也推動了PoC診斷的普及，因為早期發現對於健康管理至關重要。不斷上漲的醫療成本和政府的支持性政策進一步推動了市場擴張。新興市場醫療基礎設施的快速發展蘊藏著許多機會。專注於提供價格合理且便攜的診斷解決方案的公司有望佔據可觀的市場佔有率。此外，居家檢測的趨勢也為市場成長開闢了新的途徑，滿足了日益注重健康的消費者對便利高效檢測的需求。

限制與挑戰：

基層醫療即時診斷市場面臨許多重大限制和挑戰。其中一項主要挑戰是嚴格的監管環境，這可能會延緩新型診斷測試的核准和商業化。這種複雜的監管環境通常會導致市場准入成本增加和批准週期延長。另一項挑戰是限制性的報銷政策，這可能會因資金限制而阻礙醫療機構採用這些診斷技術。此外，技術挑戰也不容忽視，因為整合先進技術需要大量的投資和專業知識。另外，各地區缺乏標準化的通訊協定，也增加了診斷流程執行和一致性的難度。最後，資料隱私問題和網路安全威脅構成重大風險，因為強而有力的安全措施對於保護敏感的病患資訊至關重要。這些挑戰共同阻礙了市場的成長潛力，亟需制定策略性解決方案來克服這些挑戰。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 橫向流動化驗
    • 免疫檢測
    • 分子診斷
    • 血液學
    • 臨床化學
    • 微生物學
    • 凝血
    • 尿液檢查
  • 市場規模及預測：依產品分類
    • 裝置
    • 成套工具
    • 試劑
    • 消耗品
    • 軟體
  • 市場規模及預測：依服務分類
    • 安裝
    • 維護和檢查
    • 訓練
    • 諮詢
    • 資料管理
  • 市場規模及預測：依技術分類
    • 生物感測器
    • 微流體技術
    • 實驗室晶片
    • 核酸擴增
    • 電化學檢測
  • 市場規模及預測：依應用領域分類
    • 感染疾病
    • 慢性病
    • 腫瘤學
    • 心臟病學
    • 內分泌學
    • 胃腸病學
    • 腎臟病學
    • 兒童
    • 婦科
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 按部門
    • 門診治療中心
    • 居家醫療
    • 診斷檢查室
    • 藥局
    • 研究所
  • 市場規模及預測：依設備分類
    • 手持式
    • 工作台
    • 可攜式的
    • 穿戴式裝置
  • 市場規模及預測：依發展狀況
    • 本地部署
    • 基於雲端的
    • 混合
  • 市場規模及預測：依安裝類型分類
    • 新推出
    • 改裝
    • 升級
  • 市場規模及預測：按解決方案分類
    • 資料整合
    • 遠端監控
    • 病患管理
    • 品管
    • 最佳化您的工作流程

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • QuidelOrtho
  • Bio-Rad Laboratories
  • Cepheid
  • BioMerieux
  • Hologic
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Beckman Coulter
  • Nova Biomedical
  • Alere
  • Randox Laboratories
  • Sekisui Diagnostics
  • Trinity Biotech
  • Meridian Bioscience
  • EKF Diagnostics
  • Luminex Corporation

第9章：關於我們

簡介目錄
Product Code: GIS33196

Primary Care PoC Diagnostics Market is anticipated to expand from $19.7 billion in 2024 to $26.7 billion by 2034, growing at a CAGR of approximately 3.1%. The Primary Care PoC Diagnostics Market encompasses decentralized testing solutions that deliver rapid diagnostic results at the point of care. These tools empower primary care providers by enhancing patient management through swift decision-making. The market is driven by technological advancements, increasing chronic disease prevalence, and a shift towards patient-centric healthcare. Innovations focus on improving accuracy, connectivity, and ease of use, aligning with the growing demand for efficient, cost-effective healthcare delivery.

The Primary Care PoC Diagnostics Market is experiencing robust growth, propelled by an increasing emphasis on rapid and accurate diagnostic solutions. The infectious disease testing segment is the top-performing sub-segment, driven by the rising need for swift disease detection and management. Within this segment, tests for respiratory infections and sexually transmitted infections are particularly prominent, reflecting heightened awareness and preventive healthcare measures. The second-highest performing sub-segment is hematology testing, which benefits from technological advancements and the increasing prevalence of blood-related disorders. The integration of digital technologies and connectivity solutions is enhancing the capabilities of PoC diagnostics, allowing for real-time data sharing and improved patient management. Innovations in microfluidics and biosensors are further expanding diagnostic possibilities, offering more comprehensive and less invasive testing options. As healthcare systems increasingly prioritize patient-centric care, the demand for efficient, decentralized diagnostic solutions is expected to drive market growth, presenting lucrative opportunities for stakeholders.

Market Segmentation
TypeLateral Flow Assays, Immunoassays, Molecular Diagnostics, Hematology, Clinical Chemistry, Microbiology, Coagulation, Urinalysis
ProductInstruments, Kits, Reagents, Consumables, Software
ServicesInstallation, Maintenance, Training, Consultation, Data Management
TechnologyBiosensors, Microfluidics, Lab-on-a-chip, Nucleic Acid Amplification, Electrochemical Detection
ApplicationInfectious Diseases, Chronic Diseases, Oncology, Cardiology, Endocrinology, Gastroenterology, Nephrology, Pediatrics, Gynecology
End UserHospitals, Clinics, Ambulatory Care Centers, Home Care, Diagnostic Laboratories, Pharmacies, Research Institutes
DeviceHandheld, Benchtop, Portable, Wearable
DeploymentOn-premise, Cloud-based, Hybrid
Installation TypeNew Installation, Retrofit, Upgrade
SolutionsData Integration, Remote Monitoring, Patient Management, Quality Control, Workflow Optimization

Market Snapshot:

In the Primary Care PoC Diagnostics Market, the landscape is characterized by diverse market share distribution, influenced by strategic pricing and the launch of innovative products. Companies are focusing on expanding their portfolios with advanced diagnostic solutions, enhancing their competitive edge. The market is witnessing a surge in demand for point-of-care testing, driven by the need for rapid and accurate diagnostics in primary care settings. This trend is further propelled by technological advancements and the increasing prevalence of chronic diseases, which necessitate timely intervention and monitoring. Competition benchmarking reveals a dynamic environment, with key players vying for dominance through strategic partnerships and acquisitions. Regulatory influences play a pivotal role, as stringent standards ensure the reliability and safety of diagnostic tools. The market is shaped by varying regulatory landscapes across regions, impacting product approvals and market entry strategies. Companies are leveraging these insights to navigate the complex regulatory frameworks, optimizing their market positioning. The competitive landscape is further defined by innovation in diagnostic technologies, offering significant opportunities for growth and differentiation.

Geographical Overview:

The Primary Care Point-of-Care (PoC) Diagnostics Market is witnessing substantial growth across diverse regions, each presenting unique opportunities. North America leads this market, driven by an increasing demand for rapid diagnostic solutions in primary healthcare settings. The region's robust healthcare infrastructure and technological advancements contribute to its dominance. Europe follows, with a strong focus on enhancing patient care and reducing healthcare costs. The region's emphasis on early diagnosis and preventive care bolsters the market's expansion. In the Asia Pacific, burgeoning healthcare needs and rising awareness about PoC diagnostics are fueling growth. Emerging economies like India and China are pivotal, given their large populations and improving healthcare access. Latin America and the Middle East & Africa are burgeoning markets with untapped potential. Latin America's growing healthcare investments and the Middle East & Africa's increasing focus on healthcare innovation present lucrative opportunities for market players aiming to expand their global footprint.

Key Trends and Drivers:

The Primary Care PoC Diagnostics Market is experiencing robust growth, driven by technological advancements and the rising prevalence of chronic diseases. Key trends include the integration of artificial intelligence and machine learning, enhancing diagnostic accuracy and operational efficiency. The demand for rapid testing solutions is increasing, fueled by the need for timely diagnosis and treatment, particularly in rural and underserved areas. Furthermore, the market is witnessing a shift towards personalized medicine, with diagnostics playing a crucial role in tailoring treatments to individual patient needs. The emphasis on preventive healthcare is also propelling the adoption of PoC diagnostics, as early detection becomes paramount in managing health outcomes. Increasing healthcare expenditure and supportive government policies are further bolstering market expansion. Opportunities abound in emerging markets, where healthcare infrastructure is developing rapidly. Companies focusing on affordable and portable diagnostic solutions are well-positioned to capture significant market share. Additionally, the growing trend of home-based testing presents new avenues for market growth, catering to the needs of an increasingly health-conscious population seeking convenience and efficiency.

Restraints and Challenges:

The Primary Care PoC Diagnostics Market encounters several significant restraints and challenges. A primary challenge is the stringent regulatory landscape, which can delay the approval and commercialization of new diagnostic tests. This regulatory complexity often results in increased costs and extended timeframes for market entry. Another challenge is the limited reimbursement policies, which can deter healthcare providers from adopting these diagnostics due to financial constraints. The market also faces technological challenges, as the integration of advanced technologies requires substantial investment and expertise. Additionally, there is a lack of standardized protocols across different regions, complicating the implementation and consistency of diagnostic procedures. Lastly, data privacy concerns and cybersecurity threats pose significant risks, as sensitive patient information must be protected, requiring robust security measures. These challenges collectively hinder the market's growth potential and necessitate strategic solutions to overcome them.

Key Players:

QuidelOrtho, Bio-Rad Laboratories, Cepheid, BioMerieux, Hologic, Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Sysmex Corporation, Ortho Clinical Diagnostics, Beckman Coulter, Nova Biomedical, Alere, Randox Laboratories, Sekisui Diagnostics, Trinity Biotech, Meridian Bioscience, EKF Diagnostics, Luminex Corporation

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Installation Type
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Lateral Flow Assays
    • 4.1.2 Immunoassays
    • 4.1.3 Molecular Diagnostics
    • 4.1.4 Hematology
    • 4.1.5 Clinical Chemistry
    • 4.1.6 Microbiology
    • 4.1.7 Coagulation
    • 4.1.8 Urinalysis
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Kits
    • 4.2.3 Reagents
    • 4.2.4 Consumables
    • 4.2.5 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Installation
    • 4.3.2 Maintenance
    • 4.3.3 Training
    • 4.3.4 Consultation
    • 4.3.5 Data Management
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Biosensors
    • 4.4.2 Microfluidics
    • 4.4.3 Lab-on-a-chip
    • 4.4.4 Nucleic Acid Amplification
    • 4.4.5 Electrochemical Detection
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Infectious Diseases
    • 4.5.2 Chronic Diseases
    • 4.5.3 Oncology
    • 4.5.4 Cardiology
    • 4.5.5 Endocrinology
    • 4.5.6 Gastroenterology
    • 4.5.7 Nephrology
    • 4.5.8 Pediatrics
    • 4.5.9 Gynecology
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Clinics
    • 4.6.3 Ambulatory Care Centers
    • 4.6.4 Home Care
    • 4.6.5 Diagnostic Laboratories
    • 4.6.6 Pharmacies
    • 4.6.7 Research Institutes
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Handheld
    • 4.7.2 Benchtop
    • 4.7.3 Portable
    • 4.7.4 Wearable
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-premise
    • 4.8.2 Cloud-based
    • 4.8.3 Hybrid
  • 4.9 Market Size & Forecast by Installation Type (2020-2035)
    • 4.9.1 New Installation
    • 4.9.2 Retrofit
    • 4.9.3 Upgrade
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Data Integration
    • 4.10.2 Remote Monitoring
    • 4.10.3 Patient Management
    • 4.10.4 Quality Control
    • 4.10.5 Workflow Optimization

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Device
      • 5.2.1.8 Deployment
      • 5.2.1.9 Installation Type
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Device
      • 5.2.2.8 Deployment
      • 5.2.2.9 Installation Type
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Device
      • 5.2.3.8 Deployment
      • 5.2.3.9 Installation Type
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Device
      • 5.3.1.8 Deployment
      • 5.3.1.9 Installation Type
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Device
      • 5.3.2.8 Deployment
      • 5.3.2.9 Installation Type
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Device
      • 5.3.3.8 Deployment
      • 5.3.3.9 Installation Type
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Device
      • 5.4.1.8 Deployment
      • 5.4.1.9 Installation Type
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Device
      • 5.4.2.8 Deployment
      • 5.4.2.9 Installation Type
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Device
      • 5.4.3.8 Deployment
      • 5.4.3.9 Installation Type
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Device
      • 5.4.4.8 Deployment
      • 5.4.4.9 Installation Type
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Device
      • 5.4.5.8 Deployment
      • 5.4.5.9 Installation Type
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Device
      • 5.4.6.8 Deployment
      • 5.4.6.9 Installation Type
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Device
      • 5.4.7.8 Deployment
      • 5.4.7.9 Installation Type
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Device
      • 5.5.1.8 Deployment
      • 5.5.1.9 Installation Type
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Device
      • 5.5.2.8 Deployment
      • 5.5.2.9 Installation Type
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Device
      • 5.5.3.8 Deployment
      • 5.5.3.9 Installation Type
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Device
      • 5.5.4.8 Deployment
      • 5.5.4.9 Installation Type
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Device
      • 5.5.5.8 Deployment
      • 5.5.5.9 Installation Type
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Device
      • 5.5.6.8 Deployment
      • 5.5.6.9 Installation Type
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Device
      • 5.6.1.8 Deployment
      • 5.6.1.9 Installation Type
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Device
      • 5.6.2.8 Deployment
      • 5.6.2.9 Installation Type
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Device
      • 5.6.3.8 Deployment
      • 5.6.3.9 Installation Type
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Device
      • 5.6.4.8 Deployment
      • 5.6.4.9 Installation Type
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Device
      • 5.6.5.8 Deployment
      • 5.6.5.9 Installation Type
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 QuidelOrtho
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bio-Rad Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Cepheid
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 BioMerieux
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Hologic
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Roche Diagnostics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Abbott Laboratories
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Siemens Healthineers
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Thermo Fisher Scientific
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Sysmex Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Ortho Clinical Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Beckman Coulter
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Nova Biomedical
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Alere
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Randox Laboratories
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Sekisui Diagnostics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Trinity Biotech
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Meridian Bioscience
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 EKF Diagnostics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Luminex Corporation
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us